Skip to main content

Advertisement

SpringerLink
Log in

Hilar Cholangiocarcinoma: A Review and Commentary

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Hilar cholangiocarcinoma is an uncommon cause of malignant biliary obstruction marked by local tumor spread for which surgery offers the only chance of cure. The diagnostic evaluation and surgical management of this disease continues to evolve. Although direct cholangiography and endoscopic biliary procedures have been used extensively to anatomically define the extent of tumor involvement, establish biliary decompression, and obtain histological confirmation of tumor, reliance on these invasive procedures is no longer necessary, and may be detrimental. Current noninvasive imaging technology permits accurate staging of the primary tumor and has improved patient selection for operative intervention without the need for invasive procedures. Overall survival has improved in accordance with an increasingly aggressive surgical approach. The propensity of this tumor for local invasion has led most experienced hepatobiliary centers to perform a partial hepatectomy in 50% to 100% of cases. Three-year survival rates of 35% to 50% can be achieved when negative histological margins are attained at the time of surgery. When resection is not feasible, either operative bilioenteric bypass or percutaneous transhepatic intubation can achieve significant palliation. There is no effective adjuvant therapy for this disease, and unless clear indications of unresectability exist, most patients should be considered for surgical exploration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Kirschbaum JD, Kozoll DC. Carcinoma of the gall bladder and extrahepatic bile ducts. SGO 1941;73:740–753.

    Google Scholar 

  2. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75:171–190.

    PubMed  CAS  Google Scholar 

  3. Nakeeb A, Pitt HA, Sohn TA, Coleman J, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463–475.

    PubMed  CAS  Google Scholar 

  4. Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma. Ann Surg 1981;194:447–455.

    PubMed  CAS  Google Scholar 

  5. Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the bile duct (gall bladder and periampullary excluded). Ann Surg 1991;213:236–241.

    PubMed  CAS  Google Scholar 

  6. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg 1995;32:1–90.

    CAS  Google Scholar 

  7. Thuluvath PJ, Rai R, Vembrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306–315.

    PubMed  CAS  Google Scholar 

  8. Blumgart LH, Benjamin IS. Cancer of the bile ducts. In: Blumgart LH, ed. Surgery of the Liver and Biliary Tract. 2nd ed. London:Churchill Livingstone, 1994:1051–1067.

    Google Scholar 

  9. Hadjis NS, Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990;107:597–604.

    PubMed  CAS  Google Scholar 

  10. Burke E, Jarnigan WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH. Hilar cholangiocarcinoma patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385–394.

    Article  CAS  PubMed  Google Scholar 

  11. Hochwald SN, Burke E, Jarnigan WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:251–266.

    Google Scholar 

  12. Jarnigan WR, Burke E, Power C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patient with malignant obstruction at the hepatic duct confluence. Am J Surg 1998;175:453–460.

    Google Scholar 

  13. Karsten TM, Allema JH, Reinders M, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 1996;162:881–888.

    PubMed  CAS  Google Scholar 

  14. McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB, Allison DJ, Blumgart LH. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984;71:371–375.

    CAS  PubMed  Google Scholar 

  15. Temudon T, Sarr MG, Douglas MG, Farnell MB. An argument against the routine percutaneous biopsy, ERCP, or biliary stent placement in patients with clinically resectable periampullary masses: a surgical perspective. Pancreas 1995;11:283–288.

    Article  Google Scholar 

  16. Heslin MJ, Brooks AD, Hochwald SN, Blumgart LH, Brennan MF. A preoperative biliary stent is associated with increased complications after pancreaticoduodenectomy. Arch Surg 1998;133:149–154.

    PubMed  CAS  Google Scholar 

  17. Valek V, Ruzicka M. Preoperative drainage of the biliary tract in patients with obstructive jaundice. Rozhl Chir 1995;74:235–238.

    PubMed  CAS  Google Scholar 

  18. Elyaderani MK, McDowell DE, Zimmermann B. Percutaneous transhepatic catheterization in reconstructive surgery of the biliary ducts. South Med J 1985;78:142–149.

    PubMed  CAS  Google Scholar 

  19. Shaked A, Colonna JO, Goldstein L, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992;215:598–605.

    PubMed  CAS  Google Scholar 

  20. Sako K, Seitzinger GL, Garside E. Carcinoma of the extra-hepatic bile ducts: review of the literature and report of six cases. Surgery 1957;41:416–437.

    PubMed  CAS  Google Scholar 

  21. Kuwayti K, Baggenstoss AH, Stauffer MH, Preistley JI. Carcinoma of the major intrahepatic and extrahepatic bile ducts exclusive of the papilla of Vater. SGO 1957;104:357–366.

    PubMed  CAS  Google Scholar 

  22. Weinbren K, Mutumm SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217–238.

    CAS  PubMed  Google Scholar 

  23. Shimada H, Nimoto S, Matsuba A, et al. The infiltration of the bile duct carcinoma along the bile duct wall. Int Surg 1988;73:87–90.

    PubMed  CAS  Google Scholar 

  24. Skamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct cancer: a histological analysis of 62 resected cases. Ann Surg 1998;227:405–411.

    Google Scholar 

  25. Gertsch P, Thomas P, Baer H, Lerut J, Zimmermann A, Blumgart LH. Multiple tumors of the biliary tract. Am J Surg 1990;159:386–388.

    PubMed  CAS  Google Scholar 

  26. Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of hilar cholangiocarcinoma. SGO 1992;175:579–588.

    PubMed  CAS  Google Scholar 

  27. Hann LE, Fong Y, Shriver CD, et al. Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability? J Ultrasound Med 1996;15:37–45.

    PubMed  CAS  Google Scholar 

  28. Schwartz LH, Coakley FV, Sun Y, Blumgart LH, Fong Y, Panicek DM. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol 1998;170:1491–1495.

    PubMed  CAS  Google Scholar 

  29. Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 1996;201:347–351.

    PubMed  CAS  Google Scholar 

  30. Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary disease: 3D MR cholangiopancreatography. Radiology 1997;202:663–669.

    PubMed  CAS  Google Scholar 

  31. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991;161:57–62.

    Article  CAS  PubMed  Google Scholar 

  32. Ryan ME. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139–142.

    Article  PubMed  CAS  Google Scholar 

  33. American Joint Committee on Cancer, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.

    Google Scholar 

  34. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. SGO 1975;140:170–178.

    PubMed  CAS  Google Scholar 

  35. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31–38.

    CAS  PubMed  Google Scholar 

  36. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival. Cancer 1992;70:1498–1501.

    PubMed  CAS  Google Scholar 

  37. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 1996;224:628–638.

    PubMed  CAS  Google Scholar 

  38. Chamberlain RS, Blumgart LH. The surgical approach to cholangiocarcinoma. Curr Med Lit Gastroenterol 1999;18:24–40.

    Google Scholar 

  39. Tsuzuki T, Ueda M, Kuramochi S, et al. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival. Surgery 1990;108:495–501.

    PubMed  CAS  Google Scholar 

  40. Baer HU, Stain S, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resection in hilar cholangiocarcinoma. Ann Surg 1993;217:20–27.

    CAS  PubMed  Google Scholar 

  41. Nagorney DM, Donohue JH, Farnell M, Sckleck LD, Ilstrup DM. Outcomes after curative resection of cholangiocarcinoma. Arch Surg 1993;128:871–879.

    PubMed  CAS  Google Scholar 

  42. Suigura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994;115:445–451.

    Google Scholar 

  43. Su C-H, Tsay S-H, Wu C-C, et al. Factors influencing postoperative morbidity, mortality, and survival after liver resection for hilar cholangiocarcinoma. Ann Surg 1996;223:384–394.

    PubMed  CAS  Google Scholar 

  44. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998;227:70–79.

    PubMed  CAS  Google Scholar 

  45. Figueras J, Llado-Garriga L, Lama C, et al. Resection as elective treatment of hilar cholangiocarcinoma. Gastroenterol Hepatol 1998;21:218–223.

    PubMed  CAS  Google Scholar 

  46. Nagino M, Nimura Y, Kamiya J, et al. Segmental liver resection for hilar cholangiocarcinoma. Hepatogastroenterology 1998;45:7–13.

    PubMed  CAS  Google Scholar 

  47. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998;123:131–136.

    Article  CAS  PubMed  Google Scholar 

  48. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;14:535–544.

    PubMed  CAS  Google Scholar 

  49. Ringe B, Witteking C, Bechstein WO, Buzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancies: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1988;209:88–98.

    Article  Google Scholar 

  50. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26–34.

    PubMed  CAS  Google Scholar 

  51. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358–364.

    PubMed  CAS  Google Scholar 

  52. Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobil Pancreat Surg 1998;5:48–51.

    CAS  Google Scholar 

  53. Shapiro MJ. Management of malignant biliary obstruction: nonoperative and palliative techniques. Oncology 1995;9:493–496.

    PubMed  CAS  Google Scholar 

  54. Schmassmann A, von Guten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996;91:654–659.

    PubMed  CAS  Google Scholar 

  55. Pack BT, Islami AH. Tumors of the Liver. Berlin: Springer-Verlag, 1970.

    Google Scholar 

  56. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995;82:1522–1555.

    PubMed  CAS  Google Scholar 

  57. Leung JT, Kuan R. Intraluminal brachytherapy in the treatment of bile duct carcinomas. Australas Radiol 1997;41:151–154.

    PubMed  CAS  Google Scholar 

  58. Vallis KA, Benjamin IS, Munro AJ, et al. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol 1996;41:61–66.

    CAS  PubMed  Google Scholar 

  59. McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997;174:605–609.

    PubMed  CAS  Google Scholar 

  60. Hishinuma S, Ogata Y, Matsui J, Ozawa I, Imura J. Preoperative radiotherapy for cancer of the extrahepatic bile duct. Am J Clin Oncol 1998;21:203–208.

    PubMed  CAS  Google Scholar 

  61. Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998;82:2321–2325.

    PubMed  CAS  Google Scholar 

  62. Patt YZ, Jones DV, Hoque A, et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer. J Clin Oncol 1996;14:2311–2315.

    PubMed  CAS  Google Scholar 

  63. Ravry MJ, Omura GA, Bartolucci AA, Einhorn L, Kramer C, Davila E. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial. Cancer Treat Res 1986;70:311–312.

    CAS  Google Scholar 

  64. Bukowski RM, Leichman LP, Rivkin SE. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group Study. Eur J Cancer Clin Oncol 1983;19:721–723.

    PubMed  CAS  Google Scholar 

  65. Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114:536–542.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York

    Ronald S. Chamberlain MD

  2. Hepatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

    Leslie H. Blumgart MD, FACS, FRCS

  3. Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021

    Leslie H. Blumgart MD, FACS, FRCS

Authors
  1. Ronald S. Chamberlain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie H. Blumgart MD, FACS, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie H. Blumgart MD, FACS, FRCS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamberlain, R.S., Blumgart, L.H. Hilar Cholangiocarcinoma: A Review and Commentary. Ann Surg Oncol 7, 55–66 (2000). https://doi.org/10.1007/s10434-000-0055-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-000-0055-4

Keywords

Search

Navigation